Effects of caspofungin, Candida albicans and Aspergillus fumigatus on toll-like receptor 9 of GM-CSF-stimulated PMNs

The possible involvement of Toll-like receptors (TLRs) 1, 2, 4 and 9 in the interaction of antifungal drugs with polymorphonuclear neutrophils (PMNs) in response to Aspergillus fumigatus and Candida albicans as stimuli was investigated. Caspofungin revealed the broadest capacity to enable C. albican...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Salvenmoser, Stefanie (VerfasserIn) , Seidler, Marc (VerfasserIn) , Dalpke, Alexander (VerfasserIn) , Müller, Frank-Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 01 October 2010
In: FEMS immunology and medical microbiology
Year: 2010, Jahrgang: 60, Heft: 1, Pages: 74-77
ISSN:1574-695X
DOI:10.1111/j.1574-695X.2010.00720.x
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/j.1574-695X.2010.00720.x
Volltext
Verfasserangaben:Stefanie Salvenmoser, Marc J. Seidler, Alexander Dalpke & Frank-Michael C. Müller

MARC

LEADER 00000caa a2200000 c 4500
001 1851320733
003 DE-627
005 20230710124820.0
007 cr uuu---uuuuu
008 230630s2010 xx |||||o 00| ||eng c
024 7 |a 10.1111/j.1574-695X.2010.00720.x  |2 doi 
035 |a (DE-627)1851320733 
035 |a (DE-599)KXP1851320733 
035 |a (OCoLC)1389793767 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Salvenmoser, Stefanie  |e VerfasserIn  |0 (DE-588)1293208957  |0 (DE-627)1850554307  |4 aut 
245 1 0 |a Effects of caspofungin, Candida albicans and Aspergillus fumigatus on toll-like receptor 9 of GM-CSF-stimulated PMNs  |c Stefanie Salvenmoser, Marc J. Seidler, Alexander Dalpke & Frank-Michael C. Müller 
264 1 |c 01 October 2010 
300 |a 4 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 30.06.2023 
520 |a The possible involvement of Toll-like receptors (TLRs) 1, 2, 4 and 9 in the interaction of antifungal drugs with polymorphonuclear neutrophils (PMNs) in response to Aspergillus fumigatus and Candida albicans as stimuli was investigated. Caspofungin revealed the broadest capacity to enable C. albicans and A. fumigatus to stimulate TLR upregulation, TLR 2 by A. fumigatus and TLRs 4, 9 by C. albicans. Conventional amphotericin B (cAMB) stimulated only A. fumigatus to induce TLRs 2 and 4 upregulation; voriconazole stimulated A. fumigatus and fluconazole C. albicans to induce TLR 9 upregulation. For cAMB, only TLR 9 was upregulated by A. fumigatus, whereas in the case of voriconazole, TLRs 2, 4, 9 were upregulated. Caspofungin revealed the broadest capacity: C. albicans was stimulated to upregulate TLRs at least at one of the concentrations, and A. fumigatus was stimulated to upregulate TLRs 2, 4. TLR 9 was upregulated two to three fold by all antifungal drugs on protein, except for fluconazole at the RNA level. Candida albicans preincubated with caspofungin has additional effects on CD11b expression and IL8 chemotaxis in CpG-DNA-stimulated PMNs. These results indicate a relevant upregulation with a functional relevance of TLR 9 in the presence of C. albicans strains preincubated with caspofungin at three concentrations. 
700 1 |a Seidler, Marc  |d 1976-  |e VerfasserIn  |0 (DE-588)141083859  |0 (DE-627)624917126  |0 (DE-576)322091993  |4 aut 
700 1 |a Dalpke, Alexander  |d 1971-  |e VerfasserIn  |0 (DE-588)123821878  |0 (DE-627)706438523  |0 (DE-576)293894272  |4 aut 
700 1 |a Müller, Frank-Michael  |e VerfasserIn  |0 (DE-588)1131201906  |0 (DE-627)885586905  |0 (DE-576)487895827  |4 aut 
773 0 8 |i Enthalten in  |a Federation of European Microbiological Societies  |t FEMS immunology and medical microbiology  |d Oxford [u.a.] : Wiley-Blackwell, 1993  |g 60(2010), 1 vom: Okt., Seite 74-77  |h Online-Ressource  |w (DE-627)306659441  |w (DE-600)1500464-8  |w (DE-576)081986181  |x 1574-695X  |7 nnas 
773 1 8 |g volume:60  |g year:2010  |g number:1  |g month:10  |g pages:74-77  |g extent:4  |a Effects of caspofungin, Candida albicans and Aspergillus fumigatus on toll-like receptor 9 of GM-CSF-stimulated PMNs 
856 4 0 |u https://doi.org/10.1111/j.1574-695X.2010.00720.x  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230630 
993 |a Article 
994 |a 2010 
998 |g 1131201906  |a Müller, Frank-Michael  |m 1131201906:Müller, Frank-Michael  |d 50000  |e 50000PM1131201906  |k 0/50000/  |p 4  |y j 
998 |g 123821878  |a Dalpke, Alexander  |m 123821878:Dalpke, Alexander  |d 50000  |e 50000PD123821878  |k 0/50000/  |p 3 
998 |g 141083859  |a Seidler, Marc  |m 141083859:Seidler, Marc  |d 50000  |e 50000PS141083859  |k 0/50000/  |p 2 
999 |a KXP-PPN1851320733  |e 4344898028 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1851320733","title":[{"title_sort":"Effects of caspofungin, Candida albicans and Aspergillus fumigatus on toll-like receptor 9 of GM-CSF-stimulated PMNs","title":"Effects of caspofungin, Candida albicans and Aspergillus fumigatus on toll-like receptor 9 of GM-CSF-stimulated PMNs"}],"name":{"displayForm":["Stefanie Salvenmoser, Marc J. Seidler, Alexander Dalpke & Frank-Michael C. Müller"]},"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"4 S."}],"note":["Gesehen am 30.06.2023"],"person":[{"given":"Stefanie","role":"aut","display":"Salvenmoser, Stefanie","family":"Salvenmoser","roleDisplay":"VerfasserIn"},{"family":"Seidler","roleDisplay":"VerfasserIn","given":"Marc","role":"aut","display":"Seidler, Marc"},{"display":"Dalpke, Alexander","role":"aut","given":"Alexander","roleDisplay":"VerfasserIn","family":"Dalpke"},{"roleDisplay":"VerfasserIn","family":"Müller","given":"Frank-Michael","display":"Müller, Frank-Michael","role":"aut"}],"origin":[{"dateIssuedDisp":"01 October 2010","dateIssuedKey":"2010"}],"relHost":[{"pubHistory":["Nachgewiesen 6.1993 - 66.2012"],"language":["eng"],"corporate":[{"roleDisplay":"VerfasserIn","role":"aut","display":"Federation of European Microbiological Societies"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"name":{"displayForm":["Federation of European Microbiology Societies"]},"part":{"pages":"74-77","text":"60(2010), 1 vom: Okt., Seite 74-77","year":"2010","volume":"60","issue":"1","extent":"4"},"title":[{"title_sort":"FEMS immunology and medical microbiology","title":"FEMS immunology and medical microbiology"}],"disp":"Federation of European Microbiological SocietiesFEMS immunology and medical microbiology","recId":"306659441","titleAlt":[{"title":"Immunology and medical microbiology"}],"id":{"zdb":["1500464-8"],"eki":["306659441"],"doi":["10.1111/(ISSN)1574-695X"],"issn":["1574-695X"]},"origin":[{"publisherPlace":"Oxford [u.a.] ; Amsterdam [u.a.] ; Oxford [u.a.]","dateIssuedDisp":"1993-2012","publisher":"Wiley-Blackwell ; Elsevier Science ; Blackwell","dateIssuedKey":"1993"}],"note":["Gesehen am 21. Juli 2016"],"physDesc":[{"extent":"Online-Ressource"}]}],"id":{"eki":["1851320733"],"doi":["10.1111/j.1574-695X.2010.00720.x"]}} 
SRT |a SALVENMOSEEFFECTSOFC0120